BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22427315)

  • 1. Congenital nephrogenic diabetes insipidus: the current state of affairs.
    Wesche D; Deen PM; Knoers NV
    Pediatr Nephrol; 2012 Dec; 27(12):2183-204. PubMed ID: 22427315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephrogenic diabetes insipidus].
    Velásquez-Jones L; Medeiros-Domingo M
    Bol Med Hosp Infant Mex; 2014; 71(6):332-338. PubMed ID: 29421628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ; Knoers NV; van Os CH; Deen PM
    Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.
    Bockenhauer D; Bichet DG
    Nat Rev Nephrol; 2015 Oct; 11(10):576-88. PubMed ID: 26077742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?
    Boone M; Deen PM
    Exp Physiol; 2009 Feb; 94(2):186-90. PubMed ID: 18790812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus.
    Jung HJ; Kwon TH
    Kidney Res Clin Pract; 2019 Jun; 38(2):145-158. PubMed ID: 31189221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic Diabetes Insipidus.
    Balla A; Hunyady L
    Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary nephrogenic diabetes insipidus].
    Morin D; Ala Y; Dumas R
    Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
    Ando F
    Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.
    Moon SS; Kim HJ; Choi YK; Seo HA; Jeon JH; Lee JE; Lee JY; Kwon TH; Kim JG; Kim BW; Lee IK
    Endocr J; 2009; 56(7):905-10. PubMed ID: 19461158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.